Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)A Randomized-Withdrawal Phase 3 Study Evaluating the Safety and Efficacy of Oral Nalfurafine HCl (AC-820)in Subjects on Hemodialysis With Uremic Pruritus (Renal Itch)
Phase 3
- Conditions
- Uremic Pruritus
- Interventions
- First Posted Date
- 2008-11-19
- Last Posted Date
- 2010-02-04
- Lead Sponsor
- Acologix, Inc.
- Target Recruit Count
- 350
- Registration Number
- NCT00793156
An Observational Study of Pruritus Amongst Hemodialysis Patients
- Conditions
- PruritusKidney Failure, ChronicHemodialysisChronic Disease
- First Posted Date
- 2008-07-15
- Last Posted Date
- 2008-07-15
- Lead Sponsor
- Acologix, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT00715260
- Locations
- 🇺🇸
Kidney Care Associates, Augusta, Georgia, United States
🇺🇸FMC Metaire, Metaire, Louisiana, United States
🇺🇸Western New England Renal Associates, Springfield, Massachusetts, United States
News
No news found